Therapies / Engineering / Immunity / Cancer / Therapeutics / Protein / Research / Boston blog main / Boston top stories / Europe / Europe blog main / Europe top stories / National blog main / National top stories / New York blog main / New York top stories / San Francisco blog main / San Francisco top stories / Allogene Therapeutics / Arie Belldegrun / BioNtech / Biotech / Cancer Drugs / Carsten Linnemann / Cell Therapy / clinical trials / David Chang / deals / EcoR1 Capital / Eureka Therapeutics / FDA / Gritstone Oncology / investing / Jeito Capital / Life Sciences / Neogene Therapeutics / Neon Therapeutics / Polaris Partners / Pontifax / startups / Syncona / T-Cell FActory / TCR2 therapeutics / TPG Capital / Two River Group / Vida Ventures

Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy

Posted on: Sep 16, 2020   |   Posted by: Biotech Mag Top

Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy

Cell therapy offers another option for addressing the most difficult blood cancer cases, but such treatments, which are engineered from a patient's own immune cells, don't yet...

Continue reading ...